Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Wang Y, Drubay D, Jonas SF, Dixon-Douglas J, Acs B, Adams S, André F, Badve S, Bataillon G, Carter JM, Chia S, Cockenpot V, Colleoni MA, Criscitiello C, Curigliano G, Dackus GMHE, Demaria S, Denkert C, van Deurzen CHM, Dieci MV, Giardiello D, Goetz MP, Gray RJ, Hauptmann M, Ter Hoeve ND, Jóźwiak K, Koop EA, de Jong VMT, Joensuu H, Jules-Clément G, Kammler R, Kellokumpu-Lehtinen PL, Kim SB, Kok M, Lacroix-Triki M, Lambertini M, Lee HJ, Lemonnier J, Leon-Ferre RA, Leung S, Linderholm B, Loibl S, Martens JWM, Nielsen TO, Opdam M, Pharoah P, Penault-Llorca F, Piccart M, Pusztai, Riaz N, Vincent-Salomon A, Sparano J, Shimoi T, Sotiriou C, Suman VJ, Timmermans AM, van Diest PJ, Voogd AC, Viale G, Wolff AC, Yazaki S, Yoshida M, Salgado R, Linn SC, Schmidt MK, Loi S, Michiels S, A report on behalf of the International Immuno-Oncology Biomarker Working Group

Open source

DOI: 10.1016/j.annonc.2026.04.011
Published: 2026 Aug
Container: Annals of oncology : official journal of the European Society for Medical Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.annonc.2026.04.011,
  title = {Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.},
  author = {Wang Y and Drubay D and Jonas SF and Dixon-Douglas J and Acs B and Adams S and André F and Badve S and Bataillon G and Carter JM and Chia S and Cockenpot V and Colleoni MA and Criscitiello C and Curigliano G and Dackus GMHE and Demaria S and Denkert C and van Deurzen CHM and Dieci MV and Giardiello D and Goetz MP and Gray RJ and Hauptmann M and Ter Hoeve ND and Jóźwiak K and Koop EA and de Jong VMT and Joensuu H and Jules-Clément G and Kammler R and Kellokumpu-Lehtinen PL and Kim SB and Kok M and Lacroix-Triki M and Lambertini M and Lee HJ and Lemonnier J and Leon-Ferre RA and Leung S and Linderholm B and Loibl S and Martens JWM and Nielsen TO and Opdam M and Pharoah P and Penault-Llorca F and Piccart M and Pusztai and Riaz N and Vincent-Salomon A and Sparano J and Shimoi T and Sotiriou C and Suman VJ and Timmermans AM and van Diest PJ and Voogd AC and Viale G and Wolff AC and Yazaki S and Yoshida M and Salgado R and Linn SC and Schmidt MK and Loi S and Michiels S and A report on behalf of the International Immuno-Oncology Biomarker Working Group},
  year = {2026},
  journal = {Annals of oncology : official journal of the European Society for Medical Oncology},
  doi = {10.1016/j.annonc.2026.04.011},
  url = {https://doi.org/10.1016/j.annonc.2026.04.011}
}

RIS

TY  - JOUR
TI  - Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.
AU  - Wang Y
AU  - Drubay D
AU  - Jonas SF
AU  - Dixon-Douglas J
AU  - Acs B
AU  - Adams S
AU  - André F
AU  - Badve S
AU  - Bataillon G
AU  - Carter JM
AU  - Chia S
AU  - Cockenpot V
AU  - Colleoni MA
AU  - Criscitiello C
AU  - Curigliano G
AU  - Dackus GMHE
AU  - Demaria S
AU  - Denkert C
AU  - van Deurzen CHM
AU  - Dieci MV
AU  - Giardiello D
AU  - Goetz MP
AU  - Gray RJ
AU  - Hauptmann M
AU  - Ter Hoeve ND
AU  - Jóźwiak K
AU  - Koop EA
AU  - de Jong VMT
AU  - Joensuu H
AU  - Jules-Clément G
AU  - Kammler R
AU  - Kellokumpu-Lehtinen PL
AU  - Kim SB
AU  - Kok M
AU  - Lacroix-Triki M
AU  - Lambertini M
AU  - Lee HJ
AU  - Lemonnier J
AU  - Leon-Ferre RA
AU  - Leung S
AU  - Linderholm B
AU  - Loibl S
AU  - Martens JWM
AU  - Nielsen TO
AU  - Opdam M
AU  - Pharoah P
AU  - Penault-Llorca F
AU  - Piccart M
AU  - Pusztai
AU  - Riaz N
AU  - Vincent-Salomon A
AU  - Sparano J
AU  - Shimoi T
AU  - Sotiriou C
AU  - Suman VJ
AU  - Timmermans AM
AU  - van Diest PJ
AU  - Voogd AC
AU  - Viale G
AU  - Wolff AC
AU  - Yazaki S
AU  - Yoshida M
AU  - Salgado R
AU  - Linn SC
AU  - Schmidt MK
AU  - Loi S
AU  - Michiels S
AU  - A report on behalf of the International Immuno-Oncology Biomarker Working Group
PY  - 2026
JO  - Annals of oncology : official journal of the European Society for Medical Oncology
DO  - 10.1016/j.annonc.2026.04.011
UR  - https://doi.org/10.1016/j.annonc.2026.04.011
ER  -

APA

Y, W., D, D., SF, J., J, D., B, A., S, A., F, A., S, B., G, B., JM, C., S, C., V, C., MA, C., C, C., G, C., GMHE, D., S, D., C, D., CHM, V. D., MV, D., D, G., MP, G., RJ, G., M, H., ND, T. H., K, J., EA, K., VMT, D. J., H, J., G, J., R, K., PL, K., SB, K., M, K., M, L., M, L., HJ, L., J, L., RA, L., S, L., B, L., S, L., JWM, M., TO, N., M, O., P, P., F, P., M, P., Pusztai, N, R., A, V., J, S., T, S., C, S., VJ, S., AM, T., PJ, V. D., AC, V., G, V., AC, W., S, Y., M, Y., R, S., SC, L., MK, S., S, L., S, M., & Group, A. R. O. B. O. T. I. I. B. W. (2026). Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2026.04.011

Source records

pubmed · retrieved 2026-09-25T23:10:59.495Z